T2 Biosystems closed fiscal year 2023 with $34.8M in total assets, $62.8M in total liabilities and -$28.0M in shareholder equity. This represents an increase of 1.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2012 to 2023, and the quarters T2 Biosystems has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TTOO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.8M+1.4% | $34.3M-43.3% | $60.5M-23.4% | $79.1M+177.6% | $28.5M-55.7% | $64.3M+17.2% | $54.9M-38.7% | $89.6M+3.2% | $86.8M+9.7% | $79.1M+148.2% | $31.9M | N/A |
| Total Liabilities | $62.8M-15.1% | $74.0M+0.7% | $73.4M+4.4% | $70.4M+12.6% | $62.5M+18.1% | $52.9M-1.1% | $53.5M+6.6% | $50.2M+25.9% | $39.9M+52.6% | $26.1M-78.5% | $121.4M | N/A |
| Total Equity | -$28.0M+29.3% | -$39.7M-207.3% | -$12.9M-247.9% | $8.7M+125.7% | -$34.0M-398.6% | $11.4M+749.8% | $1.3M-96.6% | $39.3M-16.2% | $46.9M-11.4% | $53.0M+159.2% | -$89.5M-42.9% | -$62.7M |
TTOO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.1M-58.2% | $21.7M-41.5% | $24.8M-24.4% | $34.8M+1.4% | $43.3M-1.5% | $37.1M-6.2% | $32.7M-33.3% | $34.3M-43.3% | $44.0M-37.2% | $39.6M-49.8% | $49.0M-30.0% | $60.5M-23.4% |
| Total Liabilities | $29.8M-52.3% | $27.6M-62.5% | $62.5M-24.3% | $62.8M-15.1% | $62.5M-17.3% | $73.6M-4.6% | $82.6M+10.6% | $74.0M+0.7% | $75.6M+4.3% | $77.1M+10.4% | $74.7M+5.8% | $73.4M+4.4% |
| Total Equity | -$11.7M+39.1% | -$5.9M+83.8% | -$37.8M+24.3% | -$28.0M+29.3% | -$19.2M+39.3% | -$36.4M+2.9% | -$49.9M-94.5% | -$39.7M-207.3% | -$31.7M-1185.8% | -$37.5M-516.5% | -$25.7M-4432.0% | -$12.9M-247.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More T2 Biosystems financials
Frequently Asked Questions
What was T2 Biosystems's total assets in fiscal year 2023?
T2 Biosystems closed fiscal year 2023 with $34.8M in total assets, $62.8M in total liabilities and -$28.0M in shareholder equity.
How fast is T2 Biosystems's total assets growing?
T2 Biosystems (TTOO) total assets rose by 1.4% year over year, from $34.3M to $34.8M in fiscal year 2023.
What was T2 Biosystems's total assets in the most recent quarter?
T2 Biosystems (TTOO) reported $18.1M in total assets in Q3 2024. This represents a decrease of 58.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what T2 Biosystems (TTOO) reported on that line in every period on record.